Niflumic acid activates additional currents of the human glial L-glutamate transporter EAAT1 in a substrate-dependent manner

Biol Pharm Bull. 2013;36(12):1996-2004. doi: 10.1248/bpb.b13-00702.

Abstract

The astrocytic L-glutamate (L-Glu) transporter EAAT1 participates in the removal of L-Glu from the synaptic cleft and maintenance of non-toxic concentrations in the extracellular fluid. We have shown that niflumic acid (NFA), a non-steroidal anti-inflammatory drug (NSAIDs), alters L-Glu-induced EAAT1 currents in a voltage-dependent manner using the two-electrode voltage clamp technique in Xenopus oocytes expressing EAAT1. In this study, we characterised the effects of NFA on each type of ion-flux through EAAT1. NFA modulated currents induced by both L-Glu and L-aspartate (L-Asp) in a voltage-dependent manner. Ion-substitution experiments revealed that the activation of additional H(+) conductance was involved in the modulation of currents induced by L-Asp and L-Glu, but Cl(-) was involved only with the L-Asp currents. NFA activated additional currents of EAAT1 in a substrate-dependent manner.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Aspartic Acid / pharmacology
  • Excitatory Amino Acid Transporter 1 / physiology*
  • Glutamic Acid / pharmacology
  • Humans
  • In Vitro Techniques
  • Niflumic Acid / pharmacology*
  • Oocytes
  • Sodium / pharmacology
  • Xenopus laevis

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Excitatory Amino Acid Transporter 1
  • SLC1A3 protein, human
  • Aspartic Acid
  • Glutamic Acid
  • Niflumic Acid
  • Sodium